BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32127016)

  • 1. Robust neuroinflammation and perivascular pathology in rTg-DI rats, a novel model of microvascular cerebral amyloid angiopathy.
    Zhu X; Hatfield J; Sullivan JK; Xu F; Van Nostrand WE
    J Neuroinflammation; 2020 Mar; 17(1):78. PubMed ID: 32127016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Transgenic Rat Model of Robust Cerebral Microvascular Amyloid with Prominent Vasculopathy.
    Davis J; Xu F; Hatfield J; Lee H; Hoos MD; Popescu D; Crooks E; Kim R; Smith SO; Robinson JK; Benveniste H; Van Nostrand WE
    Am J Pathol; 2018 Dec; 188(12):2877-2889. PubMed ID: 30446159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Cognitive Decline in a Novel Rodent Model of Cerebral Amyloid Angiopathy Type-1.
    Popescu DL; Van Nostrand WE; Robinson JK
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32231123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Levels of Cerebrospinal Fluid/Plasma Aβ40 as an Early Biomarker for Cerebral Amyloid Angiopathy in RTg-DI Rats.
    Zhu X; Xu F; Hoos MD; Lee H; Benveniste H; Nostrand WEV
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31906317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. rTg-D: A novel transgenic rat model of cerebral amyloid angiopathy Type-2.
    Davis J; Xu F; Zhu X; Van Nostrand WE
    Cereb Circ Cogn Behav; 2022; 3():100133. PubMed ID: 36324401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Non-pharmacological Chronic Hypertension on a Transgenic Rat Model of Cerebral Amyloid Angiopathy.
    Stanisavljevic A; Schrader JM; Zhu X; Mattar JM; Hanks A; Xu F; Majchrzak M; Robinson JK; Van Nostrand WE
    Front Neurosci; 2022; 16():811371. PubMed ID: 35368255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct brain regional proteome changes in the rTg-DI rat model of cerebral amyloid angiopathy.
    Schrader JM; Xu F; Van Nostrand WE
    J Neurochem; 2021 Oct; 159(2):273-291. PubMed ID: 34218440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal markers of cerebral amyloid angiopathy and related inflammation in rTg-DI rats.
    Schrader JM; Xu F; Agostinucci KJ; DaSilva NA; Van Nostrand WE
    Sci Rep; 2024 Apr; 14(1):8441. PubMed ID: 38600214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct Brain Proteomic Signatures in Cerebral Small Vessel Disease Rat Models of Hypertension and Cerebral Amyloid Angiopathy.
    Schrader JM; Stanisavljevic A; Xu F; Van Nostrand WE
    J Neuropathol Exp Neurol; 2022 Aug; 81(9):731-745. PubMed ID: 35856898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse white matter loss in a transgenic rat model of cerebral amyloid angiopathy.
    Lee H; Xu F; Liu X; Koundal S; Zhu X; Davis J; Yanez D; Schrader J; Stanisavljevic A; Rothman DL; Wardlaw J; Van Nostrand WE; Benveniste H
    J Cereb Blood Flow Metab; 2021 May; 41(5):1103-1118. PubMed ID: 32791876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients.
    Vervuurt M; Schrader JM; de Kort AM; Kersten I; Wessels HJCT; Klijn CJM; Schreuder FHBM; Kuiperij HB; Gloerich J; Van Nostrand WE; Verbeek MM
    Acta Neuropathol Commun; 2024 Jan; 12(1):6. PubMed ID: 38191511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A1 reactive astrocytes and a loss of TREM2 are associated with an early stage of pathology in a mouse model of cerebral amyloid angiopathy.
    Taylor X; Cisternas P; You Y; You Y; Xiang S; Marambio Y; Zhang J; Vidal R; Lasagna-Reeves CA
    J Neuroinflammation; 2020 Jul; 17(1):223. PubMed ID: 32711525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term voluntary wheel running does not alter vascular amyloid burden but reduces neuroinflammation in the Tg-SwDI mouse model of cerebral amyloid angiopathy.
    Robison LS; Popescu DL; Anderson ME; Francis N; Hatfield J; Sullivan JK; Beigelman SI; Xu F; Anderson BJ; Van Nostrand WE; Robinson JK
    J Neuroinflammation; 2019 Jul; 16(1):144. PubMed ID: 31296239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of urokinase plasminogen activator in rodent models and patients with cerebral amyloid angiopathy.
    Vervuurt M; Zhu X; Schrader J; de Kort AM; Marques TM; Kersten I; Peters van Ton AM; Abdo WF; Schreuder FHBM; Rasing I; Terwindt GM; Wermer MJH; Greenberg SM; Klijn CJM; Kuiperij HB; Van Nostrand WE; Verbeek MM
    Neuropathol Appl Neurobiol; 2022 Aug; 48(5):e12804. PubMed ID: 35266166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-onset subicular microvascular amyloid and neuroinflammation correlate with behavioral deficits in vasculotropic mutant amyloid beta-protein precursor transgenic mice.
    Xu F; Grande AM; Robinson JK; Previti ML; Vasek M; Davis J; Van Nostrand WE
    Neuroscience; 2007 Apr; 146(1):98-107. PubMed ID: 17331655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer's disease mouse model.
    Kim SH; Ahn JH; Yang H; Lee P; Koh GY; Jeong Y
    Acta Neuropathol Commun; 2020 Nov; 8(1):181. PubMed ID: 33153499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Copper Chelation Therapy in a Transgenic Rat Model of Cerebral Amyloid Angiopathy.
    Ambi A; Stanisavljevic A; Victor TW; Lowery AW; Davis J; Van Nostrand WE; Miller LM
    ACS Chem Neurosci; 2023 Feb; 14(3):378-388. PubMed ID: 36651175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease.
    Wilcock DM; Vitek MP; Colton CA
    Neuroscience; 2009 Mar; 159(3):1055-69. PubMed ID: 19356689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive magnetic resonance imaging detection of cerebral amyloid angiopathy-related microvascular alterations using superparamagnetic iron oxide particles in APP transgenic mouse models of Alzheimer's disease: application to passive Abeta immunotherapy.
    Beckmann N; Gérard C; Abramowski D; Cannet C; Staufenbiel M
    J Neurosci; 2011 Jan; 31(3):1023-31. PubMed ID: 21248127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer's Disease Associates with Upregulated Angiopoietin and Downregulated Hypoxia-Inducible Factor.
    Skaaraas GHES; Melbye C; Puchades MA; Leung DSY; Jacobsen Ø; Rao SB; Ottersen OP; Leergaard TB; Torp R
    J Alzheimers Dis; 2021; 83(4):1651-1663. PubMed ID: 34459401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.